newsfilter
← Latest News
FDA Approved Drugs·

Approval of Skyrizi, Bla #761105

Approval Date: 10/23/2026; Drug Name: Skyrizi, Bla #761105; Active Ingredients: RISANKIZUMAB-RZAA; Company: Abbvie Inc; Submission Status: Approval; Application Number: 761105

Company
ABBVIE INC
Keywords
ABBVIE INC